The Combination Therapy with Zoledronic Acid and Propranolol Improves the Trabecular Microarchitecture and Mechanical Property in an Rat Model of Postmenopausal Osteoporosis

We conducted the present study to investigate the therapeutic effects of propranolol (PRO), alone and in combination with the antiresorptive agent ZOL, in a rat model of postmenopausal osteoporosis. Female Wistar rats were OVX or sham-operated at 3 months of age. Twelve weeks after surgery, rats wer...

Descrizione completa

Dettagli Bibliografici
Autori principali: Deepak Kumar Khajuria, Rema Razdan, D. Roy Mahapatra
Natura: Articolo
Lingua:English
Pubblicazione: Wiley 2014-01-01
Serie:Journal of Osteoporosis
Accesso online:http://dx.doi.org/10.1155/2014/586431